期刊文献+

mDRA-6与尼美舒利对Jurkat细胞的杀伤效应

Lethal effect of mDRA-6 and nimesulide on Jurkat cells
下载PDF
导出
摘要 目的:探讨mDRA-6与尼美舒利对Jurkat细胞有无杀伤作用及二者有无协同效应。方法:常规培养Jurkat细胞,流式细胞术检测细胞表面DR5的表达率,MTT法检测细胞毒性作用,Hoechst33258染色观察Jurkat细胞核形态变化,流式细胞术定量分析凋亡细胞率。结果:①Jurkat细胞表面DR5的表达率为84.83%。②mDRA-6与尼美舒利均能杀伤Jurkat细胞,存在浓度依赖性。400μmol/L的尼美舒利作用细胞10小时,细胞凋亡率为11.51%;0.5ng/ml与1ng/ml的mDRA-6作用细胞10小时,细胞凋亡率分别为3.67%和6.3%;③二者联合具有较好的协同促凋亡作用,400μmol/L的尼美舒利联合0.5ng/ml与1ng/ml的mDRA-6作用细胞10小时,细胞凋亡率分别为50.38%和63.79%。结论:mDRA-6与尼美舒利均有杀伤Jurkat细胞的作用,二者具有较强的协同作用,杀伤作用是通过诱导凋亡实现的。 Objective:To study the lethal effect of either anti-human DR5 monoclonal antibody(mDRA-6) or nimesulide, and their synergistic cytotoxicity against Jurkat cells and the possible mechanism. Methods :Jurkat cells were cultured with RPMII640 meditum in regular condition. The morphology was observed under microscope. Cytotoxicity was examined by MTT assay. Apoptosis was detected by flow cytometry. Results:(1)Expression rate of DR5 on Jurkat cells was 84. 83%. (2)Both mDRA-6 and nimesulide were able to kill Jurkat cells, respectively. Concentration:dependent cytotoxicity of mDRA-6 and nimesulide was exhibited. Treated with 400 μmol/ L nimesulide for 10 h, 11.51% Jurkat cells were apoptotic. Treated with either 0. 5 ng/ml or 1 ng/ml of mDRA-6 for 10 h, 3.67% or 6. 3% of Jurkat cells were apoptotic, respectively. (3)The combination of mDRA-6 and nimesulide exhibited synergistic effect on Jurkat cells. 400 μmol/L nimesulide combined with 0. 5 ng/ml or 1 ng/ml mDRA-6 could make 50. 38% and 63.79% Jurkat cells apoptotic, respectively. Conclusion: Both mDRA-6 and nimesulide can induce Jurkat cell apoptosis. The combination of mDRA-6 and nimesulide exhibit synergistic cytotoxicity to Jurkat cells.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2007年第6期522-525,共4页 Chinese Journal of Immunology
基金 国家自然科学基金项目(30571697)资助
关键词 抗人DR5单克隆抗体 MDRA-6 尼美舒利 凋亡 JURKAT细胞 Anti-human DR5 monoclonal antibody mDRA-6 Nimesulide Apoptosis Jurkat cells
  • 相关文献

参考文献16

  • 1Wiley S R,Schooley K,Smolak P J et al.Identification and characterization of a new member of the TNF family that induces apoptosis[J].Immunity,1995;3(6):673-682.
  • 2LeBlanc H N,Ashkenazi A.Apo2L/TRAIL and its death and decoy recptors[J].Cell Death Differ,2003;10:66-75.
  • 3Pan G,Ni J,Wei Y F et al.An antagonist decoy receptor and death domain-containing receptor for TRAIL[J].Science,1997;277:815-818.
  • 4Pitti R M,Marsters S A,Ruppert S et al.Induction of apoptosis by Apo-2 ligand,a new member of the tumor necrosis factor cytokine family[J].J Biol Chem,1996;271:12687-12690.
  • 5Mongkolsapaya J,Grimes J M,Chen N et al.Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation[J].Nat Struct Biol,1999;6:1048-1053.
  • 6Walczak H,Miller R E,Ariail K et al.Tumoricidal activity of tumor necrosis factor-related apoptos-inducing ligand in vivo[J].Nat Med,1999;5:157-163.
  • 7Ichikawa K,Liu W,Zhao L et al.Tumoricidal activity of a novel anti-human DB5 monoclonal antibody without hepatocyte cytotoxicity[J].Nature Medicine,2001;7(8):954-960.
  • 8Takeda K,Yamaguchi N,Akiba H et al.Induction of tumor-specific T cell immunity by anti-DR5 antibody therapy[J].J Exper Med,2004;199(4):437-448.
  • 9Howe L R,Dannenberg A J.A role for cyclooxygenase-2 inhibitors in the prevention and treatment of cancer[J].Semin Oncol,2002;29(3 Suppl 11):111-119.
  • 10Soslow R A,Dannenberg A J,Rush D et al.COX-2 is expressed in human pulmonary,colonic,and mammary tumors[J].Cancer,2000:89(12):2637-2645.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部